George Kurtz, Director, President and CEO, on August 21, 2026, sold 17,025 shares in Crowdstrike Holdings (CRWD) for $3,245,485. Following the Form 4 filing with the SEC, Kurtz has control over a total of 8,296,019 Class A common shares of the company, with 7,896,019 shares held directly and 400,000 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1535527/000095010326012856/xslF345X05/ownership.xml
Benjamin G Wolff, Director, on August 21, 2026, sold 19,998 shares in Globalstar (GSAT) for $1,644,102. Following the Form 4 filing with the SEC, Wolff has control over a total of 4,116 voting common shares of the company, with 4,116 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1366868/000136861826000011/xslF345X05/wk-form4_1787606843.xml
Jeffrey C Kunins, Chief Product Officer & CTO, on August 21, 2026, sold 9,605 shares in Axon Enterprise (AXON) for $6,019,433. Following the Form 4 filing with the SEC, Kunins has control over a total of 184,029 common shares of the company, with 97,761 shares held directly and 86,268 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1069183/000162828026058683/xslF345X05/wk-form4_1787606325.xml
David Krempa, Chief Business Officer, on August 24, 2026, sold 25,000 shares in Eton Pharmaceuticals (ETON) for $1,626,750. Following the Form 4 filing with the SEC, Krempa has control over a total of 37,025 common shares of the company, with 37,025 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1710340/000143774926028846/xslF345X05/rdgdoc.xml